Neptunus Biology Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 6,734

Employees

  • Stock Symbol
  • 000078

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $0.19
  • (As of Friday Closing)

Neptunus Biology General Information

Description

Shenzhen Neptunus Bioengineering Co Ltd is primarily engaged in the research and development, manufacture and distribution of pharmaceutical products in China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 24th Floor, Neptune Galaxy Technology Building
  • No. 1 Kejizhong 3rd Road, Nanshan District
  • Shenzhen, Guangdong 518057
  • China
+86 0755
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • 24th Floor, Neptune Galaxy Technology Building
  • No. 1 Kejizhong 3rd Road, Nanshan District
  • Shenzhen, Guangdong 518057
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neptunus Biology Stock Performance

As of 13-Nov-2026, Neptunus Biology’s stock price is $0.19. Its current market cap is $501M with 2.63B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.19 $0.19 $0.18 - $0.81 $501M 2.63B 53.8M -$0.05

Neptunus Biology Financials Summary

As of 30-Sep-2026, Neptunus Biology has a trailing 12-month revenue of $3.09B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,868,276 2,638,526 2,132,404 2,701,303
Revenue 3,094,011 3,708,319 4,225,135 5,147,617
EBITDA (73,570) 41,316 (10,044) (39,210)
Net Income (139,189) (78,297) (166,319) (238,865)
Total Assets 3,264,134 3,763,697 3,944,921 4,557,273
Total Debt 1,476,187 1,672,061 1,448,511 1,607,960
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Neptunus Biology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neptunus Biology‘s full profile, request access.

Request a free trial

Neptunus Biology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neptunus Biology Investments & Acquisitions (6)

Neptunus Biology’s most recent deal was a Merger/Acquisition with Dongsen Pharmaceutical. The deal was made on 02-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dongsen Pharmaceutical 02-Jan-2025 Merger/Acquisition Distributors (Healthcare)
Dongsen Pharmaceutical 29-Feb-2024 Secondary Transaction - Private Distributors (Healthcare)
Haiwang Huitong Medicine 29-Feb-2024 Secondary Transaction - Private Medical Supplies
Julikang 05-Apr-2017 Later Stage VC Other Healthcare Services
Anhui Medicine Industry 24-Aug-2016 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Neptunus Biology ESG

Risk Overview

Risk Rating

Updated December, 31, 2023

26.22 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Pharmaceuticals

Industry

of 891

Rank

Percentile

Biotechnology

Subindustry

of 394

Rank

Percentile

To view Neptunus Biology’s complete esg history, request access »

Neptunus Biology Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Dongsen Pharmaceutical Nanyang, China 2002

Neptunus Biology FAQs

  • When was Neptunus Biology founded?

    Neptunus Biology was founded in 1992.

  • Where is Neptunus Biology headquartered?

    Neptunus Biology is headquartered in Shenzhen, China.

  • What is the size of Neptunus Biology?

    Neptunus Biology has 6,734 total employees.

  • What industry is Neptunus Biology in?

    Neptunus Biology’s primary industry is Pharmaceuticals.

  • Is Neptunus Biology a private or public company?

    Neptunus Biology is a Public company.

  • What is Neptunus Biology’s stock symbol?

    The ticker symbol for Neptunus Biology is 000078.

  • What is the current stock price of Neptunus Biology?

    As of 13-Nov-2026 the stock price of Neptunus Biology is $0.19.

  • What is the current market cap of Neptunus Biology?

    The current market capitalization of Neptunus Biology is $501M.

  • What is Neptunus Biology’s current revenue?

    The trailing twelve month revenue for Neptunus Biology is $3.09B.

  • What is Neptunus Biology’s annual earnings per share (EPS)?

    Neptunus Biology’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process